10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2022 | |||
Consolidated Statements of Earnings | |||
Period Ending Jan 1, 2023 10-K (Filed: Feb 16, 2023) | |||
(In Millions, except shares in Thousands) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Jan 1, 2023 | Jan 2, 2022 | Jan 3, 2021 | |
Sales to customers | $ 94,943 | 93,775 | 82,584 |
Cost of products sold | 31,089 | 29,855 | 28,427 |
Gross profit | 63,854 | 63,920 | 54,157 |
Selling, marketing and administrative expenses | 24,765 | 24,659 | 22,084 |
Research and development expense | 14,603 | 14,714 | 12,159 |
In-process research and development (Note 5) | 783 | 900 | 181 |
Interest income | (490) | (53) | (111) |
Interest expense, net of portion capitalized (Note 4) | 276 | 183 | 201 |
Other (income) expense, net | 1,871 | 489 | 2,899 |
Restructuring (Note 20) | 321 | 252 | 247 |
Earnings before provision for taxes on income | 21,725 | 22,776 | 16,497 |
Provision for taxes on income (Note 8) | 3,784 | 1,898 | 1,783 |
Net earnings | 17,941 | 20,878 | 14,714 |
Net earnings per share (Notes 1 and 15) | |||
Basic (in dollars per share) | 6.83 | 7.93 | 5.59 |
Diluted (in dollars per share) | 6.73 | 7.81 | 5.51 |
Average shares outstanding (Notes 1 and 15) | |||
Basic (in shares) | 2,625,200 | 2,632,100 | 2,632,800 |
Diluted (in shares) | 2,663,900 | 2,674,000 | 2,670,700 |
External Links | |
JOHNSON & JOHNSON (JNJ) Fiscal Year 2022 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |